The total number of petitions for inter partes review (IPR) at the Patent Trial and Appeal Board (PTAB) has plummeted over ...
Researchers have solved a long-standing mystery of how abnormal chromosomes drive cancer, identifying 81 new genes involved ...
As genome editing therapies move through clinical trials to regulatory approval, scientists continue the quest for the holy ...